These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16477060)

  • 1. Nonpatentable drugs and the cost of our ignorance.
    Calon F
    CMAJ; 2006 Feb; 174(4):483-4. PubMed ID: 16477060
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of the private sector in biotechnology: research and development.
    Feisee L
    Health Matrix Clevel; 2002; 12(2):357-65. PubMed ID: 12430359
    [No Abstract]   [Full Text] [Related]  

  • 3. The Human Genome Project: a public good.
    Hudson K
    Health Matrix Clevel; 2002; 12(2):367-75. PubMed ID: 12430360
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioterrorism and patent rights: "compulsory licensure" and the case of Cipro.
    Resnik DB; DeVille KA
    Am J Bioeth; 2002; 2(3):29-39. PubMed ID: 12230852
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceutical company-sponsored drug trials: what are we to believe?
    Shekelle P
    J Clin Epidemiol; 2010 Feb; 63(2):126-7. PubMed ID: 19836207
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmaceutical company-sponsored drug trials: the system is broken.
    Gartlehner G; Fleg A
    J Clin Epidemiol; 2010 Feb; 63(2):128-9. PubMed ID: 19880288
    [No Abstract]   [Full Text] [Related]  

  • 7. Not-for-profit drugs--no longer an oxymoron?
    Sharp D
    Lancet; 2004 Oct 23-29; 364(9444):1472-4. PubMed ID: 15500876
    [No Abstract]   [Full Text] [Related]  

  • 8. Medicine. The intangible value of vaccination.
    Rappuoli R; Miller HI; Falkow S
    Science; 2002 Aug; 297(5583):937-9. PubMed ID: 12169712
    [No Abstract]   [Full Text] [Related]  

  • 9. Capitalizing on commercialization: should congress revisit the Bayh-Dole Act?
    Bruckbauer S
    J Natl Cancer Inst; 2003 Oct; 95(19):1429-31. PubMed ID: 14519745
    [No Abstract]   [Full Text] [Related]  

  • 10. Global health. Public-private partnerships proliferate.
    Cohen J
    Science; 2006 Jan; 311(5758):167. PubMed ID: 16410497
    [No Abstract]   [Full Text] [Related]  

  • 11. Patent medicine.
    Baker D
    J Public Health Policy; 2001; 22(3):275-9. PubMed ID: 11603309
    [No Abstract]   [Full Text] [Related]  

  • 12. Win-win interactions between the public and private sectors.
    Batson A
    Nat Med; 1998 May; 4(5 Suppl):487-91. PubMed ID: 9585192
    [No Abstract]   [Full Text] [Related]  

  • 13. Public-private partnerships in drug development for underdeveloped countries: an interview with Craig Wheeler, President of Chiron's Biopharmaceutical Division. Interview by Thomasine Kushner.
    Wheeler C
    Camb Q Healthc Ethics; 2003; 12(4):429-33. PubMed ID: 14619375
    [No Abstract]   [Full Text] [Related]  

  • 14. The global drug gap.
    Reich MR
    Science; 2000 Mar; 287(5460):1979-81. PubMed ID: 10755953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond government intervention: drug companies and bioethics.
    Dresser R
    Am J Bioeth; 2002; 2(3):42-3. PubMed ID: 12230855
    [No Abstract]   [Full Text] [Related]  

  • 16. Industry and academia in transition.
    Kennedy D
    Science; 2003 Nov; 302(5649):1293. PubMed ID: 14631000
    [No Abstract]   [Full Text] [Related]  

  • 17. Mega-trials for blockbusters.
    Ioannidis JP
    JAMA; 2013 Jan; 309(3):239-40. PubMed ID: 23321760
    [No Abstract]   [Full Text] [Related]  

  • 18. Support for trials of promising medications through the Pharmaceutical Benefits Scheme.
    Bell KD
    Med J Aust; 1995 Apr; 162(8):447; author reply 447-8. PubMed ID: 7746194
    [No Abstract]   [Full Text] [Related]  

  • 19. [Does the public sector have an independent research role in the development of drugs?].
    Poulsen HE; Grønlykke TB
    Ugeskr Laeger; 2003 Apr; 165(16):1674-6. PubMed ID: 12756828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patents, biomedical research, and treatments: examining concerns, canvassing solutions.
    Johnston J; Wasunna AA;
    Hastings Cent Rep; 2007; 37(1):S1-36. PubMed ID: 17348259
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.